{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/revolution-medicines-inc/","json":"https://alysly.com/json/markets/stocks/revolution-medicines-inc/index.json","lang":"en-US","title":"Revolution Medicines Inc. (RVMD) Stock Price Today | News","description":"Revolution Medicines Inc. (RVMD). Health Care stock, United States. ISIN US76155X1000. Held in 17 ETFs (top 0.48% in XUHL).","modified":"2026-11-01T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/revolution-medicines-inc/","json":"https://alysly.com/json/de/maerkte/aktien/revolution-medicines-inc/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Revolution Medicines Inc.","url":"https://alysly.com/markets/stocks/revolution-medicines-inc/"}],"content":[{"type":"heading","level":1,"text":"Revolution Medicines Inc. (RVMD)"},{"type":"paragraph","text":"RVMD · Health Care · United States","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"United States","href":"https://alysly.com/markets/stocks/browse/?country=United%20States"}]},{"type":"paragraph","text":"Revolution Medicines Inc. (RVMD) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.48%. Anyone who holds an ETF containing Revolution Medicines also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Revolution Medicines"},{"type":"heading","level":3,"text":"Key Data for Revolution Medicines"},{"type":"facts","items":[{"label":"Held in","value":"17 ETFs"},{"label":"Highest weight","value":"0.48%"},{"label":"Indices","value":"8"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"United States"},{"label":"ISIN","value":"US76155X1000"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":3,"text":"Revolution Medicines Stock Price Chart"},{"type":"paragraph","text":"The Revolution Medicines chart shows daily closing prices and is set to the current year by default. The stock is up 140.2% year to date and up 225.0% over twelve months. The last recorded close on October 30, 2026, was $191.31, at 82% of the 52-week range."},{"type":"paragraph","text":"Price series from our database since Aug 12, 2024, 558 daily values."},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"heading","level":3,"text":"Revolution Medicines Stock Performance"},{"type":"table","caption":"Revolution Medicines stock performance","rows":[["Year to date","+140.2%","1 year","+225.0%"],["1 month","-6.8%","3 months","+2.0%"],["Calendar year 2025","+82.1%","",""]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"Measured in euros, Revolution Medicines is up 152.6% year to date and up 236.0% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day."},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Revolution Medicines"},{"type":"heading","level":3,"text":"What ETF Is Revolution Medicines In?"},{"type":"paragraph","text":"Revolution Medicines has above-average ETF coverage and is held by 17 of the 104 ETFs we track, which together follow 8 indices. That puts the stock in more ETFs than 77.7% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"table","caption":"What ETF is Revolution Medicines in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"XUHL / XUHC","links":[{"text":"XUHL","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-health-care-ucits-etf-1c/"}]},{"text":"MSCI USA Health Care","href":"https://alysly.com/markets/indices/msci-usa-health-care/"},"0.48%","€4.81"],[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.36%","€3.56"],[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.36%","€3.56"],[{"text":"XDEM","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-momentum-ucits-etf-1c/"},{"text":"MSCI World Momentum","href":"https://alysly.com/markets/indices/msci-world-momentum/"},"0.19%","€1.90"],[{"text":"XD9U / XD9D","links":[{"text":"XD9U","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-ucits-etf-1c/"}]},{"text":"MSCI USA","href":"https://alysly.com/markets/indices/msci-usa/"},"0.05%","€0.49"],[{"text":"SWWD","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-ucits-etf-dist/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.04%","€0.41"],[{"text":"SPPW","href":"https://alysly.com/markets/etfs/spdr-msci-world-ucits-etf/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.04%","€0.41"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.04%","€0.40"],[{"text":"XDWD / XDWL","links":[{"text":"XDWD","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ucits-etf-1c/"}]},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.04%","€0.35"],[{"text":"SPYY","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-ucits-etf-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.03%","€0.30"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.03%","€0.30"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"0.03%","€0.30"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"0.02%","€0.23"]]},{"type":"paragraph","text":"Data note 6","href":"#dn-6"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Revolution Medicines, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding Revolution Medicines (weight per latest SEC filing): ONEQ 0.09%, VTI 0.05%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"ONEQ","href":"https://alysly.com/markets/etfs/us/oneq/"},{"text":"VTI","href":"https://alysly.com/markets/etfs/us/vti/"}]},{"type":"list","ordered":false,"items":[{"text":"Revolution Medicines among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 17 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Revolution Medicines overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"Which Tracked Investors Hold Revolution Medicines?"},{"type":"paragraph","text":"Revolution Medicines is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. The only manager we track that holds Revolution Medicines increased its position.","links":[{"text":"GOOGL","href":"https://alysly.com/markets/stocks/alphabet-inc-class-a/"}]},{"type":"table","caption":"Tracked investors holding this stock","columns":["Investor","Shares","Value","Quarter"],"rows":[["Duquesne Family Office","399,587","$75M","increased by 83,727"]]},{"type":"paragraph","text":"As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains."},{"type":"paragraph","text":"Data note 7","href":"#dn-7"},{"type":"heading","level":3,"text":"What Revolution Medicines Executives and Directors Traded Recently"},{"type":"table","caption":"Trades by executives and directors","columns":["Date","Person","Type","Shares","Price"],"rows":[["Oct 26, 2026","Mancini Anthony Officer, See Remarks","Sell (plan)","2,310","$186.99"],["Sep 29, 2026","Sandler Alan B. Officer, Chief Development Officer","Sell (plan)","301","$204.72"],["Sep 29, 2026","Sandler Alan B. Officer, Chief Development Officer","Sell (plan)","1,199","$203.91"],["Sep 29, 2026","Sandler Alan B. Officer, Chief Development Officer","Sell (plan)","1,000","$202.81"],["Sep 29, 2026","Sandler Alan B. Officer, Chief Development Officer","Sell (plan)","1,609","$201.72"],["Sep 29, 2026","Sandler Alan B. Officer, Chief Development Officer","Sell (plan)","2,200","$200.82"],["Sep 25, 2026","Cislini Jeff Officer, SVP & General Counsel","Sell (plan)","765","$207.32"],["Sep 25, 2026","Mancini Anthony Officer, See Remarks","Sell (plan)","3,121","$200.54"]]},{"type":"paragraph","text":"The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded."},{"type":"paragraph","text":"“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32."},{"type":"paragraph","text":"Data note 8","href":"#dn-8"},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Revolution Medicines"},{"type":"table","caption":"Stocks with ETF exposure similar to Revolution Medicines","columns":["Stock","Shared ETFs","r","1 year","Annualized volatility","Net margin","Revenue growth"],"rows":[["Revolution Medicines","–","–","+225.0%","56.2%","–","–"],[{"text":"Roivant Sciences","href":"https://alysly.com/markets/stocks/roivant-sciences-ltd/"},"17","–","+88.5%","39.4%","-3,629.2%","-71.6%"],[{"text":"Insmed Incorporated","href":"https://alysly.com/markets/stocks/insmed-incorporated/"},"16","–","-42.0%","54.9%","-210.5%","+66.7%"],[{"text":"Medline","href":"https://alysly.com/markets/stocks/medline-inc-class-a/"},"16","–","–","43.8%","4.1%","+11.5%"],[{"text":"Natera","href":"https://alysly.com/markets/stocks/natera-inc/"},"16","+0.44","+114.4%","46.7%","-9.0%","+35.9%"],[{"text":"Neurocrine Biosciences","href":"https://alysly.com/markets/stocks/neurocrine-biosciences-inc/"},"16","–","+5.8%","36.2%","16.7%","+21.4%"],[{"text":"United Therapeutics Corporation","href":"https://alysly.com/markets/stocks/united-therapeutics-corporation/"},"17","–","+32.0%","41.2%","41.9%","+10.6%"],[{"text":"Royalty Pharma Plc","href":"https://alysly.com/markets/stocks/royalty-pharma-plc-class-a/"},"17","–","+81.9%","23.4%","32.4%","+5.1%"],[{"text":"Illumina","href":"https://alysly.com/markets/stocks/illumina-inc/"},"17","–","+138.3%","47.5%","19.6%","-0.7%"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Revolution Medicines. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical."},{"type":"paragraph","text":"Data note 9","href":"#dn-9"},{"type":"heading","level":2,"id":"fundamental","text":"Fundamental Analysis: Revolution Medicines"},{"type":"heading","level":3,"text":"Revolution Medicines Key Financials"},{"type":"facts","items":[{"label":"Net income","value":"-$1.1B"},{"label":"Diluted EPS","value":"-$5.95"},{"label":"Return on equity","value":"-69.3%"},{"label":"Equity ratio","value":"69.3%"}]},{"type":"paragraph","text":"Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025)."},{"type":"table","caption":"Revenue and profit by fiscal year","columns":["Fiscal year","Revenue","Net income","Margin"],"rows":[["FY ended Dec 2023","0.0","-0.4","-3,768.3%"],["FY ended Dec 2024","0.0","-0.6","–"],["FY ended Dec 2025","0.0","-1.1","–"]]},{"type":"paragraph","text":"Data note 10","href":"#dn-10"},{"type":"heading","level":2,"id":"technical","text":"Technical Analysis: Revolution Medicines"},{"type":"heading","level":3,"text":"Revolution Medicines Risk Metrics"},{"type":"facts","items":[{"label":"Max drawdown","value":"-48.6%"},{"label":"Annualized volatility","value":"56.2%"}]},{"type":"paragraph","text":"Data note 11","href":"#dn-11"},{"type":"facts","items":[{"label":"Below peak","value":"-13.5%"},{"label":"Beta to S&P 500","value":"1.12"},{"label":"Correlation to S&P 500","value":"0.22"}]},{"type":"paragraph","text":"The close on Oct 30, 2026, was 13.5% below the highest close since Aug 12, 2024. That high was reached on Aug 27, 2026. When the S&P 500 rose or fell 1%, Revolution Medicines moved 1.12% on average in the same direction (past 252 trading days). The correlation of 0.22, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Revolution Medicines."},{"type":"paragraph","text":"Data note 12","href":"#dn-12"},{"type":"heading","level":3,"text":"What Revolution Medicines Correlates With"},{"type":"table","caption":"What Revolution Medicines Correlates With","columns":["Instrument","r","−1 … +1"],"rows":[[{"text":"argenx SE","href":"https://alysly.com/markets/stocks/argenx-se/"},"+0.50",""],[{"text":"Natera Inc.","href":"https://alysly.com/markets/stocks/natera-inc/"},"+0.44",""],[{"text":"HUMA","href":"https://alysly.com/markets/crypto/huma/"},"+0.39",""],[{"text":"Rocket Lab Corporation","href":"https://alysly.com/markets/stocks/rocket-lab-corporation/"},"+0.38",""],[{"text":"Applied Materials Inc.","href":"https://alysly.com/markets/stocks/applied-material-inc/"},"+0.36",""],[{"text":"Lam Research Corporation","href":"https://alysly.com/markets/stocks/lam-research-corporation/"},"+0.36",""],[{"text":"ACH","href":"https://alysly.com/markets/crypto/ach/"},"-0.50",""],[{"text":"XNO","href":"https://alysly.com/markets/crypto/xno/"},"-0.37",""],[{"text":"Zoetis Inc. Class A","href":"https://alysly.com/markets/stocks/zoetis-inc-class-a/"},"-0.32",""]]},{"type":"paragraph","text":"The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio."},{"type":"paragraph","text":"Data note 13","href":"#dn-13"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Revolution Medicines"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 1, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"Price history from daily closing prices; one point per trading day."},{"id":"dn-3","text":"Returns computed automatically from the price series, excluding dividends, taxes and costs."},{"id":"dn-4","text":"Daily dollar prices converted at the same day's ECB euro reference rate, then measured like the dollar return."},{"id":"dn-5","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-6","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-7","text":"Holdings as of quarter end from the mandatory filings (Form 13F) with the US securities regulator; the deadline runs up to 45 days."},{"id":"dn-8","text":"Purchases and sales by directors, officers and ten-percent owners from Form 4 filings with the US securities regulator, reported two trading days after the transaction."},{"id":"dn-9","text":"Selected by how many of the funds we track hold both names, not by business model."},{"id":"dn-10","text":"Latest reported fiscal year from XBRL annual filings with the SEC (public domain), figures in billions of US dollars; ratios computed from them."},{"id":"dn-11","text":"Computed from the full available price history."},{"id":"dn-12","text":"From daily closes: distance from the series' highest close; beta and correlation of daily returns to the S&P 500 over the last 252 trading days."},{"id":"dn-13","text":"Co-movement of daily returns over the last 90 trading days, across asset classes."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/revolution-medicines-inc/#webpage","url":"https://alysly.com/markets/stocks/revolution-medicines-inc/","name":"Revolution Medicines Inc. – Alysly","description":"Revolution Medicines Inc. (RVMD). Health Care stock, United States. ISIN US76155X1000. Held in 17 ETFs (top 0.48% in XUHL).","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-01T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/revolution-medicines-inc/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Revolution Medicines Inc."}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/revolution-medicines-inc/#entity","name":"Revolution Medicines Inc.","tickerSymbol":"RVMD","url":"https://alysly.com/markets/stocks/revolution-medicines-inc/","mainEntityOfPage":"https://alysly.com/markets/stocks/revolution-medicines-inc/","description":"Revolution Medicines Inc. (RVMD). Health Care stock, United States. ISIN US76155X1000. Held in 17 ETFs (top 0.48% in XUHL).","logo":"https://alysly.com/stock-logos/revolution-medicines-logo.webp","image":"https://alysly.com/stock-logos/revolution-medicines-logo.webp","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"RVMD"},{"@type":"PropertyValue","propertyID":"ISIN","value":"US76155X1000"}],"address":{"@type":"PostalAddress","addressCountry":"US"},"subjectOf":{"@type":"Dataset","name":"Revolution Medicines Inc. — key figures","url":"https://alysly.com/markets/stocks/revolution-medicines-inc/","description":"Revolution Medicines Inc. (RVMD). Health Care stock, United States. ISIN US76155X1000. Held in 17 ETFs (top 0.48% in XUHL).","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":17},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":0.4811},{"@type":"PropertyValue","name":"YTD return (%)","value":140.2},{"@type":"PropertyValue","name":"1-year return (%)","value":225},{"@type":"PropertyValue","name":"Sector","value":"Health Care"},{"@type":"PropertyValue","name":"Net income (USD)","unitText":"USD","value":-1131301000.0},{"@type":"PropertyValue","name":"Total assets (USD)","unitText":"USD","value":2354508000.0},{"@type":"PropertyValue","name":"Shareholders equity (USD)","unitText":"USD","value":1631297000.0},{"@type":"PropertyValue","name":"Diluted EPS (USD)","value":-5.95},{"@type":"PropertyValue","name":"Return on equity (%)","value":-69.3},{"@type":"PropertyValue","name":"Fiscal year end","value":"2025-12-31"}],"temporalCoverage":"2024-08-12/.."}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}